Maintain pressure on reforms to protect NHSMHRA issues recall of urinary incontinence drug
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class one recall of Oxybutynin Hydrochloride, a drug used to treat urinary incontinence.
Four batches of 5mg tablets of the drug have been recalled by the agency over fears they may contain too much active ingredient. The affected batch numbers are 09D02, 09D04, 146401 and 146402.
According to the MHRA, high levels of the active ingredient have been found during early stages of production of the drug. Although the finished tablets may not be affected, the agency are recalling the batches as a precautionary measure while an investigation takes place.
Oxybutynin Hydrochloride is used to treat bladder conditions, such as urinary incontinence, and is often taken by children with an uncontrollable nocturnal bladder or the elderly.
The affected batches are:
| Livery | Batch No | Expiry Date | Pack Size | First Distributed |
| Niche | 09D02 | 12/2011 | 84 | 16/04/2009 |
| Niche | 09D04 | 12/2011 | 84 | 16/04/2009 |
| Actavis | 146401 | 12/2011 | 56 | 05/05/2009 |
| Actavis | 146402 | 12/2011 | 56 | 22/05/2009 |
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.